A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
Condition: Heart Failure · Heart Failure With Reduced Ejection Fraction · Cardiovascular Diseases · Sponsor: Cardurion Pharmaceuticals, Inc.
About this study
The purpose of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart failure with reduced ejection fraction.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (139)
| Cardurion Investigative Site | Birmingham, Alabama, United States | — |
| Cardurion Investigative Site | Little Rock, Arkansas, United States | — |
| Cardurion Investigative Site | Beverly Hills, California, United States | — |
| Cardurion Investigative Site | Orange, California, United States | — |
| Cardurion Investigative Site | Torrance, California, United States | — |
| Cardurion Investigative Site | Van Nuys, California, United States | — |
| Cardurion Investigative Site | Jacksonville, Florida, United States | — |
| Cardurion Investigative Site | Miami, Florida, United States | — |
| Cardurion Investigative Site | Hazel Crest, Illinois, United States | — |
| Cardurion Investigative Site | Peoria, Illinois, United States | — |
| Cardurion Investigative Site | Alexandria, Louisiana, United States | — |
| Cardurion Investigative Site | Covington, Louisiana, United States | — |
+ 127 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06215911